Skip to main content

Joe Schwartz

Analyst

Leer Inc. Partners

Equibles does not estimate personal net worth.

About Joe Schwartz

Joe Schwartz is recorded as Analyst at Leer Inc. Partners. Joe Schwartz has spoken on 1 earnings call across 1 company, most recently for Sarepta Therapeutics, Inc. on November 5, 2026. The companies whose calls Joe Schwartz spoke on are classified in the Healthcare sector.

Joe Schwartz on recent calls

“Mike, you came from AbbVie where development is run to big pharma standards, and you've said that you want Sarepta judged on execution. Sarepta's history is mixed on clean winds and… So I'm wondering, after almost 100 days, what's your honest view of Sarepta's trial design and execution capabilities?”
Analyst — Leer Inc. Partners, Sarepta Therapeutics Third Quarter 2026 Earnings Call ·

Affiliation history

  • Leer Inc. Partners

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity